WS
TMO icon

Wedbush Securities’s Thermo Fisher Scientific TMO Stock Holding History

Wedbush Securities’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Buy
3,558
+293
+9% +$159K 0.05% 299
2025
Q4 		$1.89M Sell
3,265
-255
-7% -$144K 0.06% 268
2025
Q3 		$1.71M Sell
3,520
-546
-13% -$254K 0.06% 270
2025
Q2 		$1.65M Buy
4,066
+270
+7% +$113K 0.06% 268
2025
Q1 		$1.89M Buy
3,796
+131
+4% +$70.9K 0.07% 214
2024
Q4 		$1.91M Sell
3,665
-144
-4% -$79.2K 0.07% 206
2024
Q3 		$2.36M Sell
3,809
-493
-11% -$292K 0.09% 166
2024
Q2 		$2.38M Buy
4,302
+34
+0.8% +$19.5K 0.09% 172
2024
Q1 		$2.48M Buy
4,268
+3
+0.1% +$1.68K 0.09% 163
2023
Q4 		$2.26M Sell
4,265
-875
-17% -$424K 0.1% 151
2023
Q3 		$2.6M Sell
5,140
-203
-4% -$108K 0.13% 124
2023
Q2 		$2.79M Sell
5,343
-1,594
-23% -$860K 0.13% 123
2023
Q1 		$4M Sell
6,937
-282
-4% -$159K 0.2% 78
2022
Q4 		$3.98M Sell
7,219
-557
-7% -$295K 0.22% 72
2022
Q3 		$3.94M Sell
7,776
-234
-3% -$131K 0.22% 68
2022
Q2 		$4.35M Sell
8,010
-819
-9% -$451K 0.24% 64
2022
Q1 		$5.21M Buy
8,829
+156
+2% +$89.6K 0.24% 59
2021
Q4 		$5.79M Buy
8,673
+606
+8% +$378K 0.25% 63
2021
Q3 		$4.61M Buy
8,067
+173
+2% +$95K 0.22% 69
2021
Q2 		$3.98M Sell
7,894
-109
-1% -$51.4K 0.19% 86
2021
Q1 		$3.65M Buy
8,003
+1,215
+18% +$580K 0.2% 79
2020
Q4 		$3.16M Buy
6,788
+692
+11% +$324K 0.28% 71
2020
Q3 		$2.69M Buy
6,096
+1,140
+23% +$471K 0.26% 82
2020
Q2 		$1.8M Buy
4,956
+17
+0.3% +$5.7K 0.17% 132
2020
Q1 		$1.4M Buy
4,939
+313
+7% +$98.7K 0.17% 128
2019
Q4 		$1.5M Buy
4,626
+43
+0.9% +$13K 0.13% 175
2019
Q3 		$1.33M Buy
4,583
+202
+5% +$57.8K 0.13% 181
2019
Q2 		$1.29M Buy
4,381
+479
+12% +$132K 0.13% 180
2019
Q1 		$1.07M Sell
3,902
-37
-0.9% -$9.21K 0.11% 209
2018
Q4 		$882K Buy
3,939
+184
+5% +$43.2K 0.11% 220
2018
Q3 		$917K Buy
3,755
+140
+4% +$32.2K 0.1% 224
2018
Q2 		$749K Buy
3,615
+191
+6% +$40.5K 0.09% 248
2018
Q1 		$707K Buy
3,424
+356
+12% +$74.7K 0.09% 264
2017
Q4 		$583K Buy
3,068
+306
+11% +$58.6K 0.07% 329
2017
Q3 		$523K Sell
2,762
-88
-3% -$15.9K 0.07% 372
2017
Q2 		$497K Buy
2,850
+517
+22% +$86.8K 0.06% 393
2017
Q1 		$358K Buy
2,333
+662
+40% +$101K 0.05% 468
2016
Q4 		$236K Buy
1,671
+48
+3% +$7.08K 0.03% 600
2016
Q3 		$258K Sell
1,623
-33
-2% -$5.08K 0.04% 571
2016
Q2 		$245K Buy
1,656
+64
+4% +$9.45K 0.04% 548
2016
Q1 		$225K Buy
+1,592
New +$213K 0.04% 543
2015
Q1 		– Sell
-2,170
Closed -$272K – 779
2014
Q4 		$272K Buy
2,170
+384
+22% +$46.7K 0.04% 445
2014
Q3 		$217K Hold
1,786
– – 0.03% 515
2014
Q2 		$211K Sell
1,786
-1,000
-36% -$118K 0.03% 518
2014
Q1 		$335K Buy
2,786
+200
+8% +$23.8K 0.06% 337
2013
Q4 		$288K Buy
+2,586
New +$257K 0.07% 348

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wedbush Securities's TMO Position: Q1 2026 in Review

Wedbush Securities increased its Thermo Fisher Scientific (TMO) stake by 9% in Q1 2026, buying an estimated $159K and bringing the position to 3,558 shares worth $1.75M. The position accounts for 0.05% of the portfolio, ranked #299.

Wedbush Securities first reported a position in TMO in Q4 2013 and has held it in 46 quarters since. The position peaked at $5.79M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Wedbush Securities held 3,558 shares of Thermo Fisher Scientific worth $1.75M as of Q1 2026.
  • Wedbush Securities bought 293 Thermo Fisher Scientific shares in Q1 2026, an estimated $159K.
  • Thermo Fisher Scientific made up 0.05% of Wedbush Securities's portfolio in Q1 2026, its #299 holding.
  • Wedbush Securities first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 46 quarters since.
  • Wedbush Securities's Thermo Fisher Scientific position peaked at $5.79M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.